98-30750. Oral Dosage Form New Animal Drugs; Fenbendazole Suspension; Technical Amendment  

  • [Federal Register Volume 63, Number 222 (Wednesday, November 18, 1998)]
    [Rules and Regulations]
    [Pages 63982-63983]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-30750]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 520
    
    
    Oral Dosage Form New Animal Drugs; Fenbendazole Suspension; 
    Technical Amendment
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule; technical amendment.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulation concerning veterinary prescription use of Hoechst 
    Roussel Vet's fenbendazole suspension for cattle. The amendment 
    clarifies the oral dose of fenbendazole suspension used as a dewormer 
    in cattle.
    
    EFFECTIVE DATE: November 18, 1998.
    
    FOR FURTHER INFORMATION CONTACT: Estella Z. Jones, Center for 
    Veterinary Medicine (HFV-135), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-827-7575.
    
    SUPPLEMENTARY INFORMATION: Hoechst Roussel Vet, 30 Independence Blvd., 
    P.O. Box 4915, Warren, NJ 07059, is sponsor of new animal drug 
    application (NADA) 128-620 that provides for oral, veterinary 
    prescription use of Panacur (fenbendazole) 10 percent 
    suspension. The drug is used as a dewormer in cattle, including dairy 
    cattle of breeding age at 5 milligrams per kilogram (mg/kg) of body 
    weight, and only in beef cattle at 10 mg/kg of body weight. The 
    regulations are amended in 21 CFR 520.905a to clarify the approval.
        The amendments clarify the drug dose used to treat various classes 
    of animals and insert certain technical revisions. No additional safety 
    or effectiveness data were required. A revised freedom
    
    [[Page 63983]]
    
    of information summary is provided to reflect the clarification.
    
    List of Subjects in 21 CFR Part 520
    
        Animal drugs.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs and 
    redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is 
    amended as follows:
    
    PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
    
        The authority citation for 21 CFR part 520 continues to read as 
    follows:
        Authority: 21 U.S.C. 360b.
        2. Section 520.905a is amended by removing paragraph (a); by 
    redesignating paragraphs (b) and (c) as paragraphs (a) and (b); by 
    adding paragraph (c); by revising the heading of paragraph (d)(2); by 
    redesignating paragraph (d)(3) as paragraph (d)(4); by redesignating 
    paragraphs (d)(2)(ii), (d)(2)(ii)(A), and (d)(2)(ii)(B) as paragraphs 
    (d)(3)(i), (d)(3)(ii), and (d)(3)(iii); by adding a heading for newly 
    redesignated paragraph (d)(3); by redesignating paragraphs (d)(2)(i)(A) 
    and (d)(2)(i)(B) as paragraphs (d)(2)(ii) and (d)(2)(iii) to read as 
    follows:
    
    
    Sec. 520.905a   Fenbendazole suspension.
    
    * * * * *
        (c) Related tolerances. See Sec. 556.275 of this chapter.
        (d) * * *
        (2) Cattle including dairy cows of breeding age--* * *
    * * * * *
        (3) Beef cattle--* * *
    * * * * *
    
        Dated: November 9, 1998.
    Andrew J. Beaulieu,
    Acting Director, Office of New Animal Drug Evaluation, Center for 
    Veterinary Medicine.
    [FR Doc. 98-30750 Filed 11-17-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
11/18/1998
Published:
11/18/1998
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; technical amendment.
Document Number:
98-30750
Dates:
November 18, 1998.
Pages:
63982-63983 (2 pages)
PDF File:
98-30750.pdf
CFR: (1)
21 CFR 520.905a